PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES
$277,585,346N01FY2023AINIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAID'S GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATE TO ADVANCE.
View original record on NIH RePORTER →